SEC Tracker
Get the app

Co-Diagnostics CODX

Co-Diagnostics reported a net loss of $6.31 million for the three months ended Sep 30, 2026.

Co-Diagnostics (CODX) filed a 10-Q with the SEC on Nov 10, 2026, 4:07 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue was $282,881 for the three months ended Sep 30, 2026.
  2. Diluted EPS was -$1.01 for the three months ended Sep 30, 2026.
  3. Cash and equivalents were $714,803 as of Sep 30, 2026.

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Co-Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.